Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/93646
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Price, T.J. | - |
dc.contributor.author | Peeters, M. | - |
dc.contributor.author | Ruff, P. | - |
dc.contributor.author | Murugappan, S. | - |
dc.contributor.author | Sidhu, R. | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | The Lancet Oncology, 2014; 15(8):e303-e303 | - |
dc.identifier.issn | 1470-2045 | - |
dc.identifier.issn | 1474-5488 | - |
dc.identifier.uri | http://hdl.handle.net/2440/93646 | - |
dc.description | Correspondence | - |
dc.description.statementofresponsibility | Timothy J Price, Marc Peeters, Paul Ruff, Swaminathan Murugappan, Roger Sidhu | - |
dc.language.iso | en | - |
dc.publisher | Elsevier | - |
dc.rights | Copyright status unknown | - |
dc.source.uri | http://dx.doi.org/10.1016/s1470-2045(14)70291-8 | - |
dc.subject | Humans | - |
dc.subject | Colorectal Neoplasms | - |
dc.subject | Antineoplastic Agents | - |
dc.subject | Antibodies, Monoclonal | - |
dc.subject | Female | - |
dc.subject | Male | - |
dc.subject | Antibodies, Monoclonal, Humanized | - |
dc.title | Authors' reply | - |
dc.title.alternative | ASPECCT: panitumumab versus cetuximab for colorectal cancer – authors' reply | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/S1470-2045(14)70291-8 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Price, T.J. [0000-0002-3922-2693] | - |
dc.identifier.orcid | Peeters, M. [0000-0003-4969-2303] | - |
Appears in Collections: | Aurora harvest 7 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.